about
Group B Streptococcus early-onset disease in Emilia-romagna: review after introduction of a screening-based approachEfficacy of intrapartum chemoprophylaxis less than 4 hours durationPersistent intestinal bleeding due to severe CMV-related thrombocytopenia in a preterm newborn.Severe acquired cytomegalovirus infection in a full-term, formula-fed infant: case report.Neonatal herpes simplex virus.Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference.Fatal pneumonia following maternal HSV-1 viraemia in late pregnancy.Efficacy of a new technique - INtubate-RECruit-SURfactant-Extubate - "IN-REC-SUR-E" - in preterm neonates with respiratory distress syndrome: study protocol for a randomized controlled trial.Group B streptococcal infections in the newborn infant and the potential value of maternal vaccination.Congenital Glioblastoma multiforme and eruptive disseminated Spitz nevi.Hypothermia reduces seizure burden and improves neurological outcome in severe hypoxic-ischemic encephalopathy: an observational study.Group B streptococcal infections in a northern region of Italy.Factors associated with intrapartum transmission of group B Streptococcus.Intrapartum antibiotic prophylaxis failure and group-B streptococcus early-onset disease.The burden of early-onset sepsis in Emilia-Romagna (Italy): a 4-year, population-based study.Neonatal Group B Streptococcus Infections: Prevention Strategies, Clinical and Microbiologic Characteristics in 7 Years of Surveillance.Group B streptococcal colonization in 160 mother-baby pairs: a prospective cohort study.Impact of perinatal practices for early-onset group B Streptococcal disease prevention.L-arginine supplementation in women with chronic hypertension: impact on blood pressure and maternal and neonatal complications.Group B streptococci in milk and neonatal colonisation.Group B streptococcus late-onset disease: 2003-2010.Prevention of group B streptococcal infection in a North-Italian area.Maternal anaphylaxis and fetal brain damage after intrapartum chemoprophylaxis.Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm.Strategies for preventing group B streptococcal infections in newborns: a nation-wide survey of Italian policies.The ontogeny of fidgety movements from 4 to 20weeks post-term age in healthy full-term infants.Two Overlapping Clusters of Group B Streptococcus Late-Onset Disease in a NICU.Lotus Birth Associated With Idiopathic Neonatal Hepatitis.Group B streptococcus late-onset disease,contaminated breast milk and mothers persistently GBS negative: report of 3cases.Secondary prevention of early-onset sepsis: a less invasive Italian approach for managing neonates at risk.Are postnatal ampicillin levels actually related to the duration of intrapartum antibiotic prophylaxis prior to delivery? A pharmacokinetic study in 120 neonatesNeonates at Risk of Early-Onset Sepsis: Which Is the Best Approach?An area-based study on intrapartum antibiotic prophylaxis for preventing group B streptococcus early-onset disease: advances and limitationsInvasive neonatal GBS infections from an area-based surveillance study in ItalyUniversal Antenatal Screening for Group B Streptococcus in Emilia-romagnaAbsence of neonatal streptococcal colonization after planned cesarean section32 GBS Prevention Policies in a North Italian AreaSafety of physical examination alone for managing well-appearing neonates ≥35 weeks’ gestation at risk for early-onset sepsisIntrapartum antibiotic prophylaxis for Group B Streptococcus and risks of unnecessary antibioticsGroup B streptococcus late-onset disease and milk transmission
P50
Q28264841-70C6FA24-6B83-475F-AFD2-C2AECEE88C02Q29032061-A9C6FDEA-6767-488B-8C2B-EB8E5308FA3BQ33440843-02012B3F-FB1A-4ECF-9C78-FE365F96DFC2Q33924520-CD3E0CCD-2F9C-464C-BFD0-BB1E9BFCEB4DQ37937661-77B89E3E-BD56-48F8-9ABE-50E03B903D37Q38243879-55E2774D-2A4B-4504-A850-EBAF774A6CEAQ38251124-0925615A-4117-4A3D-A5C6-D07FAB9A9D82Q38388706-FF1B1906-32A0-413F-872B-E1FC97F66718Q38570903-BA6F7087-E571-4BB7-BC89-FCF63DBA5517Q38834732-1B8ADBB9-FBEF-49DB-9BEE-74683F75F00CQ39573672-9B289D7B-B222-4182-8B0B-9451063113FAQ40177973-32F64922-2FAB-4AAD-8B79-8D921EAC7A81Q40199872-4E2DAE6E-9481-4832-A099-CE463D7C5091Q40320047-22E13662-C8B0-4AE6-8102-C517DE9807A4Q40377045-11ABDFD8-AF09-4D92-BCB1-6740401FB6C6Q40442310-6EF18954-3B19-4062-A777-55BAF0D8C0C6Q42254596-36AAECFD-3FCC-4022-8EFC-1C04CC6DC169Q42276114-92071D85-83AC-4710-9316-CB0586F7CC25Q42854380-706C9095-C9D7-4D36-BAB2-D407FBB9BA18Q43899541-09F8C545-F3C9-4178-A59F-8AEB763247D4Q44178578-52E27788-35BC-40B5-9227-1DF966B2E79AQ44656037-391F0EB8-63CD-4591-873B-0A04C50ABFD8Q45043516-0E4E5B0F-A1F3-4210-9739-5BB81D851AA0Q45345193-2B0FB0AB-F931-4FF4-AC0E-E5F8E14D2EF0Q47146605-86F06FD3-3502-4BCA-98EE-2CC9AAC5FC62Q50478525-ECBEBC12-246C-49ED-906E-113804DFFE20Q51783300-57CC063A-E71B-4A40-B865-AD4631CA142CQ54718819-0CC9EAE1-6912-461B-BB2C-997245353A3EQ55507784-5691AC95-F3B2-4EBA-A967-55C0417E2838Q55515812-E4FA17E2-E997-4219-B469-B9E135A03D56Q56927388-1F4E76E4-98F2-4A5F-A2F9-C06D9943E157Q56927657-27CEC4DD-7083-47C0-94E2-2705DE6C9899Q56959425-D20E2CAA-E140-48A4-B933-0822A21EF36BQ59491313-07527AA6-E072-47AA-9AD4-EC4F6F6D4977Q60690351-D0C3B41D-5C49-4576-A0A6-54BC97675674Q60690367-A2442BC9-BBA3-4853-A89D-F6CE753807CEQ60690377-9F55DD0F-C545-44D0-8C91-0F8441A2D5ABQ61848703-5417E453-2B2F-47A3-A23E-1C964D6AD152Q61855293-03B3D9AD-478B-4305-96A1-76DA39E49779Q61855302-43401C0A-929C-4403-89AE-599E74020A5F
P50
description
hulumtues
@sq
researcher
@en
հետազոտող
@hy
name
Alberto Berardi
@ast
Alberto Berardi
@en
Alberto Berardi
@es
Alberto Berardi
@nl
type
label
Alberto Berardi
@ast
Alberto Berardi
@en
Alberto Berardi
@es
Alberto Berardi
@nl
prefLabel
Alberto Berardi
@ast
Alberto Berardi
@en
Alberto Berardi
@es
Alberto Berardi
@nl
P1053
A-5889-2015
P106
P1153
56283548100
P21
P31
P3829
P496
0000-0002-3534-7499